Optimization and validation of single-nucleus RNA sequencing for non-human primate BPD lungs

非人灵长类 BPD 肺单核 RNA 测序的优化和验证

• 批准号: 10570177
• 负责人: SULE CATALTEPE
• 金额: $ 21.98万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-02-10 至 2025-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10570177
• 关键词: Affect; Alveolar; Animal Model; Animals; Archives; Biological; Biomedical Research; Bronchopulmonary Dysplasia; Cell Nucleus; Cells; Cessation of life; Chronic; Collaborations; Complex; Complication; Data Set; Department chair; Development; Disease; Elements; Ensure; Epidemiology; Evidence based treatment; Extremely Low Birth Weight Infant; Formalin; Foundations; Freezing; Funding; Gene Expression Profile; Gene Expression Regulation; Genomic approach; Genomics; Gestational Age; Goals; Grant; Health; Health Sciences; Immunofluorescence Immunologic; Immunohistochemistry; Impairment; In Situ Hybridization; Infant; Interruption; Knowledge; Laboratories; Letters; Lung; Maps; Modeling; Molecular; Molecular Abnormality; National Heart, Lung, and Blood Institute; Neonatal; Neurodevelopmental Impairment; Newborn Infant; Oxygen Therapy Care; Papio; Paraffin Embedding; Pathogenesis; Pathology; Perinatal Care; Personal Communication; Pregnancy; Premature Birth; Primates; Protocols documentation; Quality Control; RNA; Research; Research Personnel; Research Proposals; Resolution; Resources; Sampling; Specimen; Steroids; Structure of parenchyma of lung; Techniques; Technology; Texas; Time; Tissues; United States; Universities; Validation; Vascularization; antenatal; biobank; cell type; cohort; cost; high risk; hospital readmission; improved; insight; lung development; new therapeutic target; nonhuman primate; novel; pediatric department; power analysis; premature lungs; preservation; programs; respiratory morbidity; single nucleus RNA-sequencing; single-cell RNA sequencing; supplemental oxygen; surfactant replacement; transcriptome; transcriptome sequencing; validation studies; ventilation

Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth, affecting approximately 18,000 infants annually in the United States. BPD causes interrupted alveolarization and vascularization in the lung, resulting in life-long chronic respiratory morbidity. Currently, there is a limited understanding of the underlying molecular pathogenesis and a shortage of evidence-based treatments for BPD. One of the most relevant animal models of BPD was generated in preterm baboons through an NHLBI-funded U01 program. As one of the past investigators of this program, we have an archive of frozen and paraffin-embedded lung tissue specimens from this model. Recent advances in single-cell genomic approaches have transformed our ability to interrogate cell types and their functional states from complex tissues. We propose that optimization and application of single-nucleus RNA-sequencing (snRNA-Seq) to our rare biorepository of non-human primate (NHP) BPD lung specimens would provide a unique opportunity to gain novel insights into the molecular pathogenesis of BPD at a single-cell resolution. Towards this goal, we have established a collaboration with Dr. Alex K. Shalek (MIT, Ragon Institute, Broad Institute), an expert and innovator in single-cell genomics, and developed the current research proposal to leverage our banked NHP BPD lung tissue specimens. The specific aims of this proposal are to: 1) optimize and validate protocols for snRNA-seq of frozen NHP lung specimens, and 2) apply these protocols to generate single-nucleus transcriptomes of developing lungs from prematurely delivered NHP infants and lungs with evolving and established BPD. To accomplish these aims, our laboratories will optimize and validate a workflow for single-nucleus isolation from control and BPD lung specimens. Power analysis strategies will be applied to determine the number of nuclei to be sequenced from each sample to achieve statistical significance across different comparisons. We will apply vigorous quality controls (QCs) to ensure the utility of our single-nucleus transcriptional profiles. Validation studies will employ bulk RNA-Seq on frozen lung samples as well as RNA in situ hybridization (RNA-ISH), immunohistochemistry and immunofluorescence on FFPE lung specimens. Final protocols will be applied to a cohort of control and BPD lung tissues to generate transcriptome maps of the NHP lungs during normal development and in early- and late- stage BPD at 3 different time points, thus providing a longitudinal assessment of molecular alterations associated with BPD. Overall, these studies will allow us to leverage a unique and well-preserved archive of newborn NHP lung specimens and generate an essential resource to inform us on temporal and spatial gene regulation at a single cell resolution during both normal lung development and BPD progression.

支气管肺发育不良（BPD）是早产最常见的并发症， 美国每年有18,000名婴儿死亡。BPD导致肺泡化和血管化中断， 肺，导致终身慢性呼吸道疾病。目前，人们对这一问题的认识有限。 潜在的分子发病机制和缺乏BPD的循证治疗。一个最 通过NHLBI资助的U 01项目在早产狒狒中产生BPD的相关动物模型。作为 作为这个项目的过去的研究者之一，我们有一份冷冻和石蜡包埋的肺组织档案， 这个模型的样本。单细胞基因组方法的最新进展已经改变了我们的能力， 从复杂组织中询问细胞类型及其功能状态。我们建议，优化和 单核RNA测序（snRNA-Seq）在我们罕见的非人灵长类动物生物库中的应用 (NHP)BPD肺标本将提供一个独特的机会，以获得新的见解的分子 BPD的发病机制在单细胞分辨率。为了实现这一目标，我们与Dr. 亚历克斯·K Shalek（麻省理工学院，Ragon研究所，Broad研究所），单细胞基因组学的专家和创新者， 开发了当前的研究方案，以利用我们的NHP BPD肺组织样本库。具体 该建议的目的是：1）优化和验证冷冻NHP肺标本的snRNA-seq的方案， 和2）应用这些方案产生发育中的肺的单核转录组， 分娩NHP婴儿和肺部，并伴有发展和确立的BPD。为了实现这些目标，我们的实验室 将优化和验证从对照和BPD肺标本中分离单个细胞核的工作流程。功率 将应用分析策略来确定每个样品中待测序的细胞核的数量， 在不同的比较中达到统计学显著性。我们将实施严格的质量控制（QC）， 确保我们的单核转录谱的实用性。验证研究将采用批量RNA-Seq， 冷冻肺样本以及RNA原位杂交（RNA-ISH）、免疫组织化学和 FFPE肺标本上的免疫荧光。最终方案将应用于对照组和BPD组 肺组织，以生成NHP肺在正常发育过程中以及在早期和晚期的转录组图谱。 在3个不同的时间点进行BPD分期，从而提供相关分子改变的纵向评估 关于BPD总的来说，这些研究将使我们能够利用一个独特的和保存良好的档案新生儿NHP 肺标本，并产生一个重要的资源，告知我们在时间和空间基因调控， 正常肺发育和BPD进展期间的单细胞消退。